Newbury Pharmaceuticals AB is a hybrid pharmaceutical company, which engages in specialty prescription drugs inn the Scandinavian markets. The company was founded by Karl Karlsson in 2020 and is headquartered in Lund, Sweden.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company